Purchase Order 75N91019P00057
Award Date 12/7/18
Potential Completion Date 1/16/19
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on June 24, 2019, for drugs and biologicals with a completion date of July 31, 2019. Work is performed in Grand Island, New York. This firm fixed-price order procures specialized biomedical research instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio—the vendor operates as a direct supplier of genetic analysis instruments, immunoassay systems, flow...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>
- <p>The National Cancer Institute issued a $32,582.74 delivery order to Life Technologies Corporation on September 17, 2018, for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers.</p> <p>Place of performance is Grand Island, NY. The order has a ceiling value of $32,582.74 with an ultimate completion date of September 24, 2018. Pricing is firm fixed price. No set-aside was used.</p>
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on May 23, 2019, for drugs and biologicals with an ultimate completion date of June 23, 2019. Work is performed in Grand Island, New York. The order is firm fixed price with no small business set-aside. Life Technologies, a wholly owned subsidiary of Thermo Fisher Scientific, supplies specialized biomedical research instruments, reagents, and consumables to federal agencies as a prime...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $24,898.13 on August 30, 2018, with ultimate completion on August 29, 2019. No set-aside category applied. Place of performance is Bethesda, Maryland. The purchase order uses fixed-price pricing with economic price adjustment. Life Technologies operates as Thermo Fisher Scientific and supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on August 5, 2015, valued at $3,011.04 for scientific instruments, reagents, or consumables with a firm fixed price structure. Performance occurred in Baltimore, Maryland, with an ultimate completion date of September 28, 2016. No set-aside applied to this simplified acquisition.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>